[Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy; D004317:Doxorubicin / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000188:drug therapy; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008722:Methods; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013739:Testosterone / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy; D014762:Viral Interference
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006728:Hormones; D013739:Testosterone; D004317:Doxorubicin; D008525:Medroxyprogesterone
Traitement médical des tumeurs malignes des os (carcinolytiques, hormonothérapie, immunothérapie)